DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 111 filers reported holding DICE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 11.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,467,355 | +62.2% | 268,346 | 0.0% | 21.26% | +38.6% |
| Q1 2023 | $7,688,113 | -8.2% | 268,346 | 0.0% | 15.34% | +12.3% |
| Q4 2022 | $8,372,395 | -23.1% | 268,346 | -50.0% | 13.67% | -19.4% |
| Q3 2022 | $10,884,000 | +30.7% | 536,693 | 0.0% | 16.95% | +47.9% |
| Q2 2022 | $8,329,000 | -18.9% | 536,693 | 0.0% | 11.46% | +46.6% |
| Q1 2022 | $10,267,000 | -24.4% | 536,693 | 0.0% | 7.82% | +27.7% |
| Q4 2021 | $13,584,000 | – | 536,693 | – | 6.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $102,737,575 | 55.73% |
| Sands Capital Ventures, LLC | 2,748,970 | $85,768 | 23.49% |
| OUP Management Co., LLC | 268,346 | $8,372,395 | 13.67% |
| New Leaf Venture Partners, L.L.C. | 371,693 | $11,596,822 | 8.40% |
| RA Capital Management | 6,848,911 | $213,686,023 | 4.33% |
| VR Adviser, LLC | 819,000 | $25,552,800 | 4.30% |
| SVB FINANCIAL GROUP | 42,358 | $1,321,570 | 3.61% |
| Logos Global Management LP | 660,000 | $20,592,000 | 2.41% |
| Deep Track Capital, LP | 1,734,143 | $54,105,262 | 2.27% |
| Samsara BioCapital, LLC | 202,773 | $6,326,518 | 1.36% |